Skip to main content

Rinvoq (Upadacitinib) & Acute Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism, and Thrombotic Stroke

    Basic Details
    Status
    Ongoing
    Last Updated
    Friday, March 1, 2024
    Original Posting Date
    Health Outcome(s)
    acute myocardial infarction (Crohn's disease)
    acute myocardial infarction (ulcerative colitis)
    deep vein thrombosis (Crohn's disease)
    deep vein thrombosis (ulcerative colitis)
    pulmonary embolism (Crohn's disease)
    pulmonary embolism (ulcerative colitis)
    thrombotic stroke (Crohn's disease)
    thrombotic stroke (ulcerative colitis)
    Purpose
    Drug and Outcome Analysis
    Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR
    No